Holista Colltech Limited

HCT

AU000000HCT4

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 01:10:13 2024-03-14 am EDT			5-day change	1st Jan Change
0.01 ^AUD	+11.11%		-.--%	-.--%

May. 15	Holista Colltech Extends Voluntary Suspension to May 22	MT
Apr. 17	Holista Colltech Requests for Extension of Voluntary Suspension	MT

Holista Colltech Limited Appoints of Blair James Michelson as Director

August 13, 2020 at 02:21 am EDT

Holista CollTech Limited announced the appointment of Blair James Michelson as Director, effective from 11 August 2020.

Latest news about Holista Colltech Limited

Holista Colltech Extends Voluntary Suspension to May 22	May. 14	MT
Holista Colltech Requests for Extension of Voluntary Suspension	Apr. 16	MT
Holista Colltech Suspended from Australian Bourse Pending Announcement	Mar. 20	MT
Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Holista Colltech's Customer Receipts Hit AU$1.8 Million in Q4	Jan. 31	MT
Holista Colltech Says Civil Penalty Federal Court Hearings Completed; Shares Climb 17%	Dec. 07	MT
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Olista Colltech Limited Announces Board Changes	23-04-05	CI
Holista Colltech Limited Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Holista Colltech's Sales Receipts Jump 55% in Q2	22-07-28	MT
Holista Colltech Limited Announces Test Results on All-Natural Nano Silver Disinfectant	22-04-29	CI
Holista Colltech Receives First Commercial Order from Country Farms	22-04-21	MT
Holista Colltech Limited Auditor Raises 'Going Concern' Doubt	22-03-29	CI
Holista CollTech Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
Holista Colltech's Sanitizer Product Demonstrates 12-Hour Effectivity	21-10-29	MT
Holista Colltech's Cash Receipts Rise in Q3	21-10-28	MT
Holista Colltech Limited Announces Natshield Test Results	21-10-28	CI
Holista Colltech : Secures Trademark Nod From Chinese Regulator	21-09-16	MT
Holista CollTech Limited Announces Change of Company Secretary	21-09-01	CI
Holista Colltech Limited Announces Change of Registered Office	21-09-01	CI
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
Holista CollTech : Corporate Regulator Sues Holista Colltech over Misleading Statements	21-08-05	MT
Holista Colltech Limited Announces Management Changes	21-07-29	CI

Chart Holista Colltech Limited

Duration

Period

More charts

Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company operates through four segments: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in the infection control solutions. The Companyâs products include LOGIC Sweet, Super Bio Silver, OVICOLL, OVINEX, low-GI bread, low-GI noodle and spaghetti, 80Less sugar, Low Fat Chip, and health supplements. The Company's subsidiaries include Holista Biotech Sdn Bhd, Alterni (M) Sdn Bhd, Revonutrix Sdn Bhd, and others.

Sector

Biotechnology & Medical Research

Calendar

2024-05-30 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HOLISTA COLLTECH LIMITED	-.--%	1.86M
MODERNA, INC.	+44.48%	55.07B
LONZA GROUP AG	+44.30%	40.22B
IQVIA HOLDINGS INC.	-0.86%	41.79B
CELLTRION, INC.	-7.59%	28.17B
ICON PUBLIC LIMITED COMPANY	+12.30%	26.28B
ALNYLAM PHARMACEUTICALS, INC.	-21.83%	18.93B
BIO-TECHNE CORPORATION	+7.15%	13.03B
MEDPACE HOLDINGS, INC.	+29.40%	12.26B
UNITED THERAPEUTICS CORPORATION	+25.15%	12.21B

Other Biotechnology & Medical Research